3NY-30164-95964
5 vaccinations
14 coded responses
56 check-ins
13 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 982 / WA
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
RRK-30089-14705
Child or adolescent in my care · Female · 2021-11-11
Timeline
-
2021-01-09
Registered in v-safe
-
2021-01-09
Dose 1 — Pfizer-BioNTech
-
2021-01-09
Survey response — day 0, dose 1MedDRA: Asthenia — Feeling: FairFree text: Generalized weakness, MILDMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Survey response — days 1–6 daily, dose 1MedDRA: Muscular weakness — Feeling: Fair · Fatigue or tirednessFree text: Bilateral leg weaknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — days 1–6 daily, dose 1MedDRA: Muscular weakness — Feeling: Good · Fatigue or tirednessFree text: Leg weaknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Survey response — days 1–6 daily, dose 1MedDRA: Muscular weakness — Feeling: GoodFree text: Leg weakness MILDMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
-
2021-01-15
Survey response — days 1–6 daily, dose 1MedDRA: Muscular weakness — Feeling: Good · Headache, Fatigue or tirednessFree text: Bilat leg weaknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — day 7, dose 1MedDRA: Muscular weakness — Feeling: GoodFree text: Leg weakness MILDMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
- 2021-01-30
-
2021-02-01
Dose 2 — Pfizer-BioNTech
- 2021-02-01
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Fatigue or tirednessAdult check-in
- 2021-02-06
- 2021-02-07
- 2021-02-08
-
2021-02-17
Survey response — day 14, dose 2MedDRA: Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Persistent headache and fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-22
-
2021-03-01
Survey response — day 28, dose 2MedDRA: Fatigue, Sensation of foreign body — Feeling: FairFree text: Persistent fatigue & lump in throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-08
Survey response — day 35, dose 2MedDRA: Fatigue, Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Continue with fatigue, runny nose, sore throat.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-15
- 2021-05-05
-
2021-11-03
Dose 3 — Pfizer-BioNTech
- 2021-11-03
-
2021-11-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-10
- 2021-11-17
- 2021-11-24
-
2021-12-03
Survey response — day 28, dose 3MedDRA: Fatigue, Headache, Retinal haemorrhage — Feeling: FairFree text: More frequent headaches and fatigue. Also small retinal hemmorhage of unknown etiology.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-08
-
2021-12-15
Survey response — day 42, dose 3MedDRA: Headache — Feeling: FairFree text: More frequent headachesMedDRA releases: 2024-11 · check-in free text available
- 2022-02-02
-
2022-05-04
Survey response — 6 months, dose 3MedDRA: Aphonia, Chills, Cough, Oropharyngeal pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Lost voice, sore throat, chills, slight coughMedDRA releases: 2024-11 · check-in free text available
-
2022-05-28
Dose 4 — Pfizer-BioNTech
-
2022-05-29
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-05-31
- 2022-06-01
- 2022-06-02
- 2022-06-06
- 2022-06-11
- 2022-06-19
- 2022-06-25
- 2022-07-04
- 2022-07-09
- 2022-08-29
-
2022-10-07
Dose 5 — Pfizer-BioNTech
- 2022-10-29
- 2022-11-10
- 2022-11-12
-
2022-11-18
Survey response — day 42, dose 5MedDRA: Lymphadenopathy, Oropharyngeal pain, Sleep disorder — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fixed lymph node, sleep issues, persistent sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-11-18
Report sent to call center — day 42, dose 5Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-22
- 2023-01-08
-
2023-04-09
Survey response — 6 months, dose 5MedDRA: Lymphadenopathy, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-09
Report sent to call center — 6 months, dose 5Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-11
- 2023-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Pfizer-BioNTech | |
| 2 | 2021-02-01 | Pfizer-BioNTech | |
| 3 | 2021-11-03 | Pfizer-BioNTech | No |
| 4 | 2022-05-28 | Pfizer-BioNTech | No |
| 5 | 2022-10-07 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Generalized weakness, MILD
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Bilateral leg weakness
Systemic reaction (other): Leg weakness
Systemic reaction (other): Leg weakness MILD
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Bilat leg weakness
Release 2 — day 7, dose 1
Systemic reaction (other): Leg weakness MILD
Release 4 — day 14, dose 2
Symptoms: Persistent headache and fatigue
Release 4 — day 28, dose 2
Symptoms: Persistent fatigue & lump in throat
Release 5 — day 35, dose 2
Symptoms: Continue with fatigue, runny nose, sore throat.
Release 10 — day 28, dose 3
Symptoms: More frequent headaches and fatigue. Also small retinal hemmorhage of unknown etiology.
Release 10 — day 42, dose 3
Symptoms: More frequent headaches
Release 11 — 6 months, dose 3
Symptoms: Lost voice, sore throat, chills, slight cough
Release 12 — day 42, dose 5
Symptoms: Fixed lymph node, sleep issues, persistent sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Aphonia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Retinal haemorrhage | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sensation of foreign body | ✓ | ✓ | ✓ |
| SD | Sleep disorder | · | · | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release